Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
55.17
+1.09 (2.02%)
At close: Nov 20, 2026, 4:00 PM EST
55.20
+0.03 (0.05%)
After-hours: Nov 20, 2026, 7:30 PM EST
Sol-Gel Technologies Revenue
Sol-Gel Technologies had revenue of $41.00K in the quarter ending September 30, 2026, a decrease of -89.75%. This brings the company's total for the last twelve months to $1.44M, down -92.43% year-over-year. In the year 2025, Sol-Gel Technologies had annual revenue of $19.39M with 68.04% growth. That makes Sol-Gel Technologies the 43,048th largest company in the world by revenue and 5,941st in the United States.
Revenue (ttm)
$1.44M
Revenue Growth
-92.43%
P/S Ratio
125.87
Revenue / Employee
$51,286
Employees
28
Market Cap
180.76M
Revenue by Geography
- United States 16.70M 86.1%
- Canada 1.68M 8.6%
- Switzerland 711.00K 3.7%
- Other 278.00K 1.4%
- China 27.00K 0.1%
Fiscal year ended Dec 31, 2025 See the full Sol-Gel Technologies breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.39M | 7.85M | 68.04% |
| Dec 31, 2024 | 11.54M | 9.98M | 642.47% |
| Dec 31, 2023 | 1.55M | -2.33M | -59.98% |
| Dec 31, 2022 | 3.88M | -27.39M | -87.58% |
| Dec 31, 2021 | 31.27M | 22.50M | 256.54% |
| Dec 31, 2020 | 8.77M | -14.13M | -61.71% |
| Dec 31, 2019 | 22.90M | 22.78M | 17,655.04% |
| Dec 31, 2018 | 129.00K | -45.00K | -25.86% |
| Dec 31, 2017 | 174.00K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compugen | 75.93M |
| Pyxis Oncology | 11.04M |
| Whitehawk Therapeutics | 7.15M |
| Entrada Therapeutics | 3.98M |
| Oramed Pharmaceuticals | 2.00M |
| Korro Bio | 1.29M |
| Cartesian Therapeutics | 1.03M |
| Palisade Bio | 500.00K |
SLGL News
- 9 days ago - Sol-Gel Technologies Earnings release: Q3 2026 - Filings
- 9 days ago - Sol-Gel Technologies reports Q3 EPS ($2.13), consensus ($2.07) - TheFly
- 9 days ago - Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 5 weeks ago - Sol-Gel Technologies Transcript: KOL event - Transcripts
- 5 weeks ago - Sol-Gel Technologies Slides: KOL event - Filings
- 5 weeks ago - Sol-Gel Technologies initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 weeks ago - Sol-Gel Technologies initiated with an Overweight at Cantor Fitzgerald - TheFly
- 7 weeks ago - Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026 - GlobeNewsWire